Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value: $887M (100.0% shares, 0.0% debt)

Holdings (38)

INSM INSMED INC 13.5%
Value $120M Shares 4,423,369 Share Price $27.13 * Est. Cost/Share $17.79 Unrealized @ Report Date +57.3%
FOLD AMICUS THERAPEUTICS INC 12.4%
Value $110M Shares 9,344,102 Share Price $11.78 * Est. Cost/Share $9.63 Unrealized @ Report Date +32.9%
BMRN BIOMARIN PHARMACEUTICAL INC 11.2%
Value $99.09M Shares 1,134,569 Share Price $87.34 * Est. Cost/Share $83.16 Unrealized @ Report Date +7.7%
BIIB BIOGEN INC 7.1%
Value $62.52M Shares 289,958 Share Price $215.63 * Est. Cost/Share $264.98 Unrealized @ Report Date -11.6%
UTHR UNITED THERAPEUTICS CORP 6.9%
Value $61.51M Shares 267,759 Share Price $229.72 Est. Cost/Share $89.23 Unrealized @ Report Date +152.9%
STAA STAAR SURGICAL CO 6.0%
Value $52.81M Shares 1,379,590 Share Price $38.28 * Est. Cost/Share $24.23 Unrealized @ Report Date +34.2%
ACAD ACADIA PHARMACEUTICALS INC 5.0%
Value $44.65M Shares 2,414,943 Share Price $18.49 * Est. Cost/Share $28.41 Unrealized @ Report Date -12.8%
PRTA PROTHENA CORP PLC 4.6%
Value $41.2M Shares 1,663,448 Share Price $24.77 * Est. Cost/Share $21.46 Unrealized @ Report Date +38.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 3.5%
Value $31.31M Shares 2,112,811 Share Price $14.82 * Est. Cost/Share $5.23 Unrealized @ Report Date +122.4%
ALNY ALNYLAM PHARMACEUTICALS INC 3.1%
Value $27.31M Shares 182,766 Share Price $149.45 * Est. Cost/Share $169.79 Unrealized @ Report Date -1.8%
SRPT SAREPTA THERAPEUTICS INC 2.9%
Value $26.06M Shares 201,265 Share Price $129.46 * Est. Cost/Share $111.32 Unrealized @ Report Date +10.0%
— REVANCE THERAPEUTICS INC 2.9%
Value $25.82M Shares 5,248,004 Share Price $4.92 Est. Cost/Share $21.40 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 2.1%
Value $18.85M Shares 1,005,776 Share Price $18.74 Est. Cost/Share $42.50 Unrealized @ Report Date —
ANAB ANAPTYSBIO INC 2.0%
Value $18.01M Shares 799,906 Share Price $22.52 * Est. Cost/Share $19.13 Unrealized @ Report Date +23.8%
EHTH EHEALTH INC 1.8%
Value $16.38M Shares 2,715,681 Share Price $6.03 * Est. Cost/Share $38.13 Unrealized @ Report Date -82.6%
ALGN ALIGN TECHNOLOGY INC 1.8%
Value $16.1M Shares 49,105 Share Price $327.92 * Est. Cost/Share $149.18 Unrealized @ Report Date +96.7%
ALKS ALKERMES PLC 1.5%
Value $13.42M Shares 495,592 Share Price $27.07 * Est. Cost/Share $22.36 Unrealized @ Report Date +27.0%
— ACELYRIN INC 1.3%
Value $11.58M Shares 1,715,180 Share Price $6.75 Est. Cost/Share $6.75 Unrealized @ Report Date —
— NEVRO CORP 1.2%
Value $10.84M Shares 750,371 Share Price $14.44 Est. Cost/Share $21.87 Unrealized @ Report Date —
SNDX SYNDAX PHARMACEUTICALS INC 1.1%
Value $9.644M Shares 405,193 Share Price $23.80 * Est. Cost/Share $16.84 Unrealized @ Report Date +32.5%
NVCR NOVOCURE LTD 1.0%
Value $8.783M Shares 561,908 Share Price $15.63 * Est. Cost/Share $58.84 Unrealized @ Report Date -75.0%
CYTK CYTOKINETICS INC 0.9%
Value $7.832M Shares 111,717 Share Price $70.11 * Est. Cost/Share $6.71 Unrealized @ Report Date +1052.1%
— KARYOPHARM THERAPEUTICS INC 0.9%
Value $7.704M Shares 5,102,193 Share Price $1.51 Est. Cost/Share $16.36 Unrealized @ Report Date —
— VERVE THERAPEUTICS INC 0.9%
Value $7.647M Shares 575,817 Share Price $13.28 Est. Cost/Share $13.94 Unrealized @ Report Date —
GOSS GOSSAMER BIO INC 0.9%
Value $7.542M Shares 6,391,775 Share Price $1.18 * Est. Cost/Share $1.58 Unrealized @ Report Date -30.3%
— ELEVATION ONCOLOGY INC 0.8%
Value $6.908M Shares 1,346,666 Share Price $5.13 Est. Cost/Share $5.13 Unrealized @ Report Date —
— BLUEBIRD BIO INC 0.7%
Value $5.837M Shares 4,560,171 Share Price $1.28 Est. Cost/Share $1.35 Unrealized @ Report Date —
RLMD RELMADA THERAPEUTICS INC 0.4%
Value $3.406M Shares 732,400 Share Price $4.65 * Est. Cost/Share $3.27 Unrealized @ Report Date +47.3%
NUVB NUVATION BIO INC 0.3%
Value $2.812M Shares 772,652 Share Price $3.64 * Est. Cost/Share $1.92 Unrealized @ Report Date 0.0%
TSHA TAYSHA GENE THERAPIES INC 0.3%
Value $2.328M Shares 811,268 Share Price $2.87 * Est. Cost/Share $2.02 Unrealized @ Report Date +2.9%
STOK STOKE THERAPEUTICS INC 0.2%
Value $1.699M Shares 125,861 Share Price $13.50 * Est. Cost/Share $6.06 Unrealized @ Report Date 0.0%
MIRM MIRUM PHARMACEUTICALS INC 0.2%
Value $1.625M Shares 64,700 Share Price $25.12 * Est. Cost/Share $15.56 Unrealized @ Report Date +76.7%
HUM HUMANA INC 0.2%
Value $1.382M Shares 3,985 Share Price $346.72 * Est. Cost/Share $369.63 Unrealized @ Report Date 0.0%
VYNE VYNE THERAPEUTICS INC 0.2%
Value $1.367M Shares 445,434 Share Price $3.07 * Est. Cost/Share $3.12 Unrealized @ Report Date -30.9%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value $854K Shares 110,719 Share Price $7.71 * Est. Cost/Share $23.56 Unrealized @ Report Date -64.2%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $737K Shares 225,465 Share Price $3.27 Est. Cost/Share $5.95 Unrealized @ Report Date -44.7%
ACRS ACLARIS THERAPEUTICS INC 0.1%
Value $707K Shares 569,832 Share Price $1.24 Est. Cost/Share $1.19 Unrealized @ Report Date 0.0%
URGN UROGEN PHARMA LTD 0.0%
Value $368K Shares 24,500 Share Price $15.00 * Est. Cost/Share $27.01 Unrealized @ Report Date -39.5%